{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T02:11:29Z","timestamp":1777774289553,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2025-21-46"],"award-info":[{"award-number":["320.6750.2025-21-46"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024\\u202FJ011084"],"award-info":[{"award-number":["2024\\u202FJ011084"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ijbiomac.2026.151615","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:31:21Z","timestamp":1774283481000},"page":"151615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Computational de novo design of an \u03b1-helical peptide targeting LIMD2 suppresses breast cancer cell proliferation"],"prefix":"10.1016","volume":"358","author":[{"given":"Qiuyan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushuai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengwen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuangui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ijbiomac.2026.151615_bb0005","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1158\/0008-5472.CAN-13-1275","article-title":"LIMD2 is a small LIM-only protein overexpressed in metastatic lesions that regulates cell motility and tumor progression by directly binding to and activating the integrin-linked kinase","volume":"74","author":"Peng","year":"2014","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151615_bb0010","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.3390\/cells9112522","article-title":"LIMD2 regulates key steps of metastasis cascade in papillary thyroid cancer cells via MAPK crosstalk","volume":"9","author":"Araldi","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151615_bb0015","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1186\/s12885-025-14402-7","article-title":"From biomarker to targeted therapy: investigating trophoblast cell-surface antigen 2 expression in triple-negative breast cancer\u2013 insights from the national cancer institute","volume":"25","author":"Ebrahim","year":"2025","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151615_bb0020","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1080\/21655979.2021.2000732","article-title":"LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway","volume":"12","author":"Chen","year":"2021","journal-title":"Bioengineered"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151615_bb0025","doi-asserted-by":"crossref","first-page":"8985","DOI":"10.1007\/s11033-023-08733-6","article-title":"Knockdown of LIMD2 inhibits the progression of ovarian carcinoma through ERK1\/2 pathway","volume":"50","author":"Hu","year":"2023","journal-title":"Mol. Biol. Rep."},{"issue":"S1","key":"10.1016\/j.ijbiomac.2026.151615_bb0030","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2018.32.1_supplement.666.1","article-title":"LIMD2 is an intracellular activator of integrin linked kinase(ILK) activity and GSK-3\/Akt\/beta-catenin signaling","volume":"32","author":"Dedhar","year":"2018","journal-title":"FASEB J."},{"issue":"1130","key":"10.1016\/j.ijbiomac.2026.151615_bb0035","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211033","article-title":"Understanding breast cancer as a global health concern","volume":"95","author":"Wilkinson","year":"2021","journal-title":"Br. J. Radiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2026.151615_bb0040","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151615_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-022-01259-6","article-title":"Targeting integrin pathways: mechanisms and advances in therapy","volume":"8","author":"Pang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151615_bb0050","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/cts.12567","article-title":"Tutorial on monoclonal antibody pharmacokinetics and its considerations in early development","volume":"11","author":"Ovacik","year":"2018","journal-title":"Clin. Transl. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151615_bb0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","article-title":"Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines","volume":"10","author":"Xiao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117961","article-title":"Peptide inhibitors: breaking cancer code","volume":"297","author":"Coburn","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151615_bb0065","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3390\/ijms26115131","article-title":"Therapeutic peptides: recent advances in discovery, synthesis, and clinical translation","volume":"26","author":"Zheng","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151615_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25102293","article-title":"Peptide therapeutics 2.0","volume":"5","author":"de la Torre","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0075","series-title":"Handbook of Biologically Active Peptides","first-page":"421","article-title":"CHAPTER 60 - analogs of luteinizing hormone-releasing hormone (LHRH) in Cancer","author":"Schally","year":"2006"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151615_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.46747\/cfp.6804271","article-title":"Endocrine therapies for breast and prostate cancers","volume":"68","author":"Chaput","year":"2022","journal-title":"Can. Fam. Physician"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151615_bb0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1021\/acsptsci.3c00269","article-title":"Peptide-drug conjugates: design, chemistry, and drug delivery system as a novel cancer theranostic","volume":"7","author":"Rizvi","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0090","article-title":"Ovarian function suppression with luteinizing hormone-releasing hormone agonists for the treatment of hormone receptor-positive early breast cancer in premenopausal women","volume":"Volume 11\u20132021","author":"Lu","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151615_bb0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13045-023-01497-3","article-title":"Recent advances in targeted strategies for triple-negative breast cancer","volume":"16","author":"Zhu","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2026.151615_bb0100","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1016\/j.apsb.2024.04.006","article-title":"Encoding and display technologies for combinatorial libraries in drug discovery: the coming of age from biology to therapy","volume":"14","author":"Fan","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0105","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.3390\/molecules200713384","article-title":"Molecular docking and structure-based drug design strategies","author":"Ferreira","year":"2015","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.ijbiomac.2026.151615_bb0110","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3390\/ph15101283","article-title":"Strategies for improving peptide stability and delivery","volume":"15","author":"Al Musaimi","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116262","article-title":"Deep learning for advancing peptide drug development: tools and methods in structure prediction and design","volume":"268","author":"Wu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"issue":"7976","key":"10.1016\/j.ijbiomac.2026.151615_bb0120","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"issue":"6615","key":"10.1016\/j.ijbiomac.2026.151615_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.add2187","article-title":"Robust deep learning\u2013based protein sequence design using ProteinMPNN","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science"},{"issue":"6604","key":"10.1016\/j.ijbiomac.2026.151615_bb0130","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.abn2100","article-title":"Scaffolding protein functional sites using deep learning","volume":"377","author":"Wang","year":"2022","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151615_bb0135","doi-asserted-by":"crossref","first-page":"eadr8638","DOI":"10.1126\/sciadv.adr8638","article-title":"De novo design of peptide binders to conformationally diverse targets with contrastive language modeling","volume":"11","author":"Bhat","year":"2025","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151615_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s42004-025-01601-3","article-title":"Design of linear and cyclic peptide binders from protein sequence information","volume":"8","author":"Li","year":"2025","journal-title":"Communications Chemistry"},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02761-2","article-title":"Target sequence-conditioned design of peptide binders using masked language modeling","author":"Chen","year":"2025","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0150","series-title":"Proceedings of the 42nd International Conference on Machine Learning","first-page":"59017","article-title":"PepTune: de novo generation of therapeutic peptides with multi-objective-guided discrete diffusion","volume":"267(article 2343)","author":"Tang","year":"2025"},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133811","article-title":"A deep attention model for wide-genome protein-peptide binding affinity prediction at a sequence level","volume":"276","author":"Sun","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151615_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018934","article-title":"Rosetta FlexPepDock ab-initio: simultaneous folding, docking and refinement of peptides onto their receptors","volume":"6","author":"Raveh","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2026.151615_bb0165","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/pharmaceutics15020431","article-title":"CSM-toxin: a web-server for predicting protein toxicity","volume":"15","author":"Morozov","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.ijbiomac.2026.151615_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020161","article-title":"RosettaScripts: a scripting language Interface to the Rosetta macromolecular modeling suite","volume":"6","author":"Fleishman","year":"2011","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.151615_bb0175","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151615_bb0180","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1016\/j.chempr.2019.07.008","article-title":"Electronic circular dichroism spectroscopy of proteins","volume":"5","author":"Rogers","year":"2019","journal-title":"Chem"},{"issue":"11","key":"10.1016\/j.ijbiomac.2026.151615_bb0185","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/nrm1499","article-title":"The LIM domain: from the cytoskeleton to the nucleus","volume":"5","author":"Kadrmas","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.151615_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167160","article-title":"A brief history of De novo protein design: minimal, rational, and computational","volume":"433","author":"Woolfson","year":"2021","journal-title":"J. Mol. Biol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2026.151615_bb0195","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.84.24.8898","article-title":"Helix stabilization by Glu-...Lys+ salt bridges in short peptides of de novo design","volume":"84","author":"Marqusee","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2026.151615_bb0200","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1021\/acs.jcim.0c00058","article-title":"Improving Protein\u2013Peptide Docking Results via Pose-Clustering and Rescoring with a Combined Knowledge-Based and MM\u2013GBSA Scoring Function","volume":"60","author":"Tao","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.sbi.2020.07.001","article-title":"Challenges in protein docking","volume":"64","author":"Vakser","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2026.151615_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612931","article-title":"Peptide-based agents for Cancer treatment: current applications and future directions","volume":"24","author":"Nh\u00e0n","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151615_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2021.101707","article-title":"Molecular docking and dynamics studies on propolis sulabiroin-a as a potential inhibitor of SARS-CoV-2","volume":"34","author":"Fatriansyah","year":"2022","journal-title":"J. King Saud Univ. - Sci."},{"issue":"20","key":"10.1016\/j.ijbiomac.2026.151615_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2025.169382","article-title":"Harnessing Allostery to Modulate Protein\u2013Protein Interactions: From Function to Therapeutic Innovations","volume":"437","author":"Mukhopadhyay","year":"2025","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.151615_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142985","article-title":"Allosteric inhibitors for the treatment of cancers (2021-): a review from medicinal chemistry perspectives","volume":"1344","author":"Ma","year":"2025","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.ijbiomac.2026.151615_bb0230","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1038\/s41598-022-16338-5","article-title":"Spatial organization of hydrophobic and charged residues affects protein thermal stability and binding affinity","volume":"12","author":"Desantis","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.ijbiomac.2026.151615_bb0235","doi-asserted-by":"crossref","first-page":"409","DOI":"10.6026\/97320630003409","article-title":"Role of large hydrophobic residues in proteins","volume":"3","author":"Jayaraj","year":"2009","journal-title":"Bioinformation"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026015412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026015412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T17:41:11Z","timestamp":1777484471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026015412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":47,"alternative-id":["S0141813026015412"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151615","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational de novo design of an \u03b1-helical peptide targeting LIMD2 suppresses breast cancer cell proliferation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.151615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151615"}}